Want to see IN:SUNPHARMA full AI Analyst Report?
Earnings Data
Report Date
Feb 04, 2027TBA (Confirmed)
Period Ending
2027 (Q3)Consensus EPS Forecast
14.2Last Year’s EPS
14.7Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA) Earnings, Revenues Date & History
IN:SUNPHARMA Q2 2027 Earnings Report
IN:SUNPHARMA Upcoming Earnings
Sun Pharmaceutical Industries Limited's next earnings date is estimated for February 4, 2027, based on past reporting schedules.
IN:SUNPHARMA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
IN:SUNPHARMA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2026 | ₹1762.95 | ₹1778.25 | +0.87% |
Jul 31, 2026 | ₹2000.75 | ₹1989.35 | -0.57% |
May 22, 2026 | ₹1886.21 | ₹1840.38 | -2.43% |
Nov 05, 2025 | ₹1677.43 | ₹1677.43 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Sun Pharmaceutical Industries Limited (IN:SUNPHARMA) report earnings?
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA) is schdueled to report earning on Feb 04, 2027, TBA (Confirmed).
What is Sun Pharmaceutical Industries Limited (IN:SUNPHARMA) earnings time?
Sun Pharmaceutical Industries Limited (IN:SUNPHARMA) earnings time is at Feb 04, 2027, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Sun Pharmaceutical Industries Limited stock?
The P/E ratio of Sun Pharmaceutical Industries Limited is N/A.
What is IN:SUNPHARMA EPS forecast?
IN:SUNPHARMA EPS forecast for the fiscal quarter 2027 (Q3) is 14.2.